Althea DRF Lifesciences is a multifaceted healthcare and wellness company with a partner driven approach to deliver innovative solutions to a range of healthcare sectors. The company was set up in 2008 as the vision of Dr. Anand C. Burman. He envisaged the revitalization of India’s healthcare and wellness space by combining the knowledge of Ayurveda with rigors of pharmaceutical product development. At the core of our business, we seek to combine our partner’s scientific expertise with our own capabilities of delivering scalable and reliable solutions to each stakeholder in the life-cycle of wellness products.
To complement our vision of providing holistic solutions to healthcare and wellness challenges, our services cover all of the critical stages in the production-cycle of medicinal products ranging from development research and clinical testing to manufacturing. Additionally, we offer a range of consulting and compliance services to help third party manufacturers abide by legislative and high-quality standards. Consequently, we maintain a diverse range of partners with a strong foothold across healthcare sectors and a diverse product catalogue to maximize our cross- sectoral impact.
The Management
Dr. Anand Burman
Chairman
Dr. Burman holds a PhD in pharmaceutical chemistry from the University of Kansas. Dr Burman set up the pharmaceutical division for Dabur India in 1989 and he is a prominent and respected figure within the international oncology industry.
Dr. Manu Jaggi
COO
Doctorate in Cancer biology from NII and a Post graduate in pharmaceutical science (gold medalist) Dr Jaggi is a seasoned scientific leader bringing over 30 years of experience in discovery research and advanced preclinical drug development.
Dr. Anu T. Singh
CSO
Doctorate in tumor biology from AIIMS and Post doctoral research in signal transduction alterations in adenocarcinomas at NII, Dr Anu is a seasoned scientific leader with over 30 years of experience in new drug discovery and early preclinical drug development.
Mr. Aditya Burman
Director
Aditya worked towards expanding the company's footprint in the overseas markets and was soon in charge of its Sales and Marketing in Latin America. Under his stewardship, Dabur Pharma emerged as a leading research-driven pharmaceutical firm with a global presence. The company was subsequently sold to Fresenius Kabi in 2008.
Our Team
Althea has a team of over 100 passionate experts recruited from the top 5 Universities of India, having over 100 years of cumulative management experience in preclinical research
Journey So Far
-
1979
Incorporated as a part of Dabur India Ltd to serve its R&D
-
2008
Althea Lifesciences Incorporated
-
2009
Expansion into therapeutic areas other than Oncology
-
2012
Expansion of GPL CRO services
-
2014
Animal facility established
-
2015
ISO & GMP Certification
-
2016
SIRO Recognition by DSIR
-
2017
GPL Accreditation
-
2018
AAALAC Accreditation
-
2019
Althea Lifesciences rebranded to Althea DRF Lifesciences
-
2020
Incorporation of DRF Althea Life Sciences UK